Cancer News and Research

Latest Cancer News and Research

Cancer Research Technology and University of Manchester announce collaboration in oncology with AstraZeneca

Cancer Research Technology Limited (CRT), the oncology-focused development and commercialisation company, and The University of Manchester have entered into an agreement with AstraZeneca to establish a clinical pharmacology biomarker research and discovery collaboration.

20 Nov 2006

Tooth whiteners found to have no negative health effects

Common tooth whitening products, which have been used by millions of people, are found to be safe and do not increase the risk of oral cancer when used as directed.

20 Nov 2006

Risk to childhood cancer survivors for late-occurring strokes

Children who are successfully treated for brain tumors or leukemia are more likely to have strokes later in life, according to new research from UT Southwestern Medical Center.

20 Nov 2006

Experimental drug provides powerful therapy against acute myeloid leukemia

Researchers at The University of Texas M. D. Anderson Cancer Center have found, in laboratory studies, that the experimental drug ABT-737 which has shown promise in some cancers, can destroy acute myeloid leukemia (AML) blast, progenitor and even stem cells that are often resistant to standard chemotherapy treatment.

19 Nov 2006

Cigarette smoking and high HPV concentrations associated with greater risk of cervical cancer

Cigarette smoking and concurrent infection with high levels of the virus associated with cervical cancer can increase cancer risk by as much as 27 times, according to a study published in the November 2006 issue of Cancer Epidemiology, Biomarkers & Prevention.

19 Nov 2006

Gene expression and lung cancer prognosis

While there have been significant advances in the use of gene expression profiling to assess a cancer prognosis, a Mayo Clinic review and analysis of existing lung cancer studies shows that this technology has not yet surpassed the accuracy of conventional methods used to assess survival in lung cancer patients.

19 Nov 2006

Evolution is driving therapeutic resistance to cancer therapies

The dynamics of evolution are fully in play within the environment of a tumor, just as they are in forests and meadows, oceans and streams.

19 Nov 2006

FDA expands use of Herceptin

The U.S. Food and Drug Administration (FDA) has expanded the approved use of Herceptin, a biological cancer drug. The new indication is for Herceptin, in combination with other cancer drugs, for the treatment of HER2 positive breast cancer after surgery (lumpectomy or mastectomy).

19 Nov 2006

FDA approves silicone gel-filled breast implants

After rigorous scientific review, the U.S. Food and Drug Administration (FDA) has approved the marketing of silicone gel-filled breast implants made by two companies for breast reconstruction in women of all ages and breast augmentation in women ages 22 and older.

19 Nov 2006

Clinician led management can fix the NHS

Clinician led management can fix the NHS, argues a senior doctor in this week's British Medical Journal. He calls on the government to let clinicians and managers plan and run their services free from political control.

19 Nov 2006

One in ten Americans endure pain which lasts for a year or more

According to the latest government statistics 1 in 10 of American adults endure pain which lasts for a year or more.

16 Nov 2006

A good wife, a good grip, a good education and no ciggies and you'll live to 85!!

According to a long-term study which was conducted over a 40 year period, among the most significant factors influencing longevity in men were a strong grip, a wife, not smoking and a good education.

15 Nov 2006

Doha Declaration on life-saving drugs for poor countries not happening

Despite the fact that the World Trade Organisation (WTO) granted a special exemption five years ago, in order that poor countries could access life-saving drug, poor people in developing countries are still dying needlessly because global pharmaceutical giants continue to monopolise drugs for diseases such as cancer and AIDS.

15 Nov 2006

40% of U.S. women ages 18 to 75 know about human papillomavirus

Forty percent of U.S. women ages 18 to 75 have heard about human papillomavirus and of those women, 20% are aware that it can cause cervical cancer, according to the National Cancer Institute's 2005 Health Information National Trends Survey, which was presented on Sunday at the American Association for Cancer Research's Frontiers in Cancer Prevention Research Meeting in Boston, Reuters Health reports.

14 Nov 2006

Testosterone replacement therapy appears to be safe - has little effect on the prostate gland

Preliminary research suggests that testosterone replacement therapy for men with low testosterone levels appears to have little effect on the prostate gland, contrary to some reports that this therapy may be harmful, according to a study in the November 15 issue of JAMA: The Journal of the American Medical Association.

14 Nov 2006

Novel way of tackling diseases related to the immune system

A new study has suggested a novel way of combating diseases related to the immune system, including cancer and autoimmune diseases such as type I diabetes and arthritis. The study, funded by the Wellcome Trust, appears online in the journal Nature.

14 Nov 2006

Lifestyle decisions that may stave off onset of cancer

Personal choices, such as smoking and consumption of fatty foods, have long been linked to increased cancer risk. During recent years, scientists have been seeking to isolate a variety of lifestyle decisions that may stave off the onset of cancer or even reduce tumor formation in their early stages.

14 Nov 2006

Food can have an impact in preventing cancer

With cancer, researchers don't believe "you are what you eat"; that disease is always a direct result of what is, or what isn't, on your dinner plate.

14 Nov 2006

Researchers identify risk factors for healthy survival in men

Avoiding health risk factors in midlife such as smoking, being overweight, excessive drinking and hypertension is associated with a longer and healthier life in men, according to a study in the November 15 issue of JAMA: The Journal of the American Medical Association, a theme issue on men's health.

14 Nov 2006

New gold standard of care for overactive bladder

A major clinical trial finds that a combination of two common medications -- tolterodine (Detrol LA) and tamsulosin (Flomax) -- works better than either drug alone for men struggling with lower urinary tract symptoms, including tough-to-treat overactive bladder (OAB).

14 Nov 2006

Cancer News and Research

Latest Cancer News and Research

Cancer Research Technology and University of Manchester announce collaboration in oncology with AstraZeneca

Tooth whiteners found to have no negative health effects

Risk to childhood cancer survivors for late-occurring strokes

Experimental drug provides powerful therapy against acute myeloid leukemia

Cigarette smoking and high HPV concentrations associated with greater risk of cervical cancer

Gene expression and lung cancer prognosis

Evolution is driving therapeutic resistance to cancer therapies

FDA expands use of Herceptin

FDA approves silicone gel-filled breast implants

Clinician led management can fix the NHS

One in ten Americans endure pain which lasts for a year or more

A good wife, a good grip, a good education and no ciggies and you'll live to 85!!

Doha Declaration on life-saving drugs for poor countries not happening

40% of U.S. women ages 18 to 75 know about human papillomavirus

Testosterone replacement therapy appears to be safe - has little effect on the prostate gland

Novel way of tackling diseases related to the immune system

Lifestyle decisions that may stave off onset of cancer

Food can have an impact in preventing cancer

Researchers identify risk factors for healthy survival in men

New gold standard of care for overactive bladder

Cancer Research - Second Edition eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in